Gentis news

The PGT Testing Process in IVF

PGT (Preimplantation Genetic Testing) is a genetic analysis performed before embryo transfer to help select the best embryos - those without abnormalities in chromosome number or structure, or without disease-causing genetic mutations - for embryo transfer. So, how is the PGT process carried out in IVF treatment?

Eurofins GENTIS provides a comprehensive PGT testing portfolio

Preimplantation Genetic Testing (PGT) is becoming an essential tool for improving IVF success rates and reducing the risk of genetic abnormalities. Eurofins GENTIS offers a comprehensive portfolio of PGT tests, utilizing advanced technologies to support the selection of healthy embryos and optimize the journey to parenthood.

Scientific seminar: Eurofins GENTIS updates PGT-M testing at Hanoi obstetrics and gynecology hospital

On April 28, 2026, at Hanoi Obstetrics and Gynecology Hospital, Eurofins Genetic Testing Service Joint Stock Company held a scientific seminar and professional exchange with doctors, specialists, and midwives from the hospital’s department of assisted reproduction & andrology. The session focused on updating in-depth knowledge about PGT-M testing - one of the key tests in assisted reproduction, which helps screen embryos for single-gene genetic disorders before embryo transfer.

Eurofins GENTIS promotes training collaboration on Clinmind software for newborn screening result interpretation

On April 24, 2026, Eurofins GENTIS organized an internal training program on Clinmind software for interpreting newborn screening test results, led directly by Dr. Nguyen Huy Dong – R&D specialist of the company. This activity is part of the strategy to enhance professional capacity, standardize analysis and data interpretation processes, and promote the application of advanced technologies in genetic screening and diagnosis.

Announcement: Update on non-invasive prenatal paternity DNA testing service

In our continuous effort to enhance service quality and deliver the best customer experience, Eurofins GENTIS is pleased to announce updates to our non-invasive prenatal paternity DNA testing service, featuring significant improvements in turnaround time and efficiency.

Genetic testing ecosystem in reproductive support at Eurofins GENTIS

The journey of finding and welcoming a child is one of the most sacred milestones for every family. However, alongside happiness comes many concerns, especially those related to reproductive health and genetic factors that may affect fertility and fetal development. In this context, proactive testing, screening, and early detection of potential risks play an essential role.

Eurofins GENTIS announces appointment of chief executive officer

Eurofins Genetic Testing Services Joint Stock Company (Eurofins GENTIS) has officially announced the appointment of Dr Nguyen Quang Vinh as chief executive officer, effective from March 23, 2026.